Introduction
With the rapid change of lifestyle and dietary pattern, vascular risk factors (VRFs) for stroke, such as hypertension and diabetes, are increasingly common among elderly adults in China [1, 2] . Data from the Framingham, Honolulu-Asia Aging and Rotterdam studies indicated that these VRFs, independent of detectable stroke or cerebral lesions, significantly increase the risk of dementia and cognitive impairment [3, 4, 5] . However, the principal pathophysiological basis of this increase has not been fully elucidated. Several trials suggested that VRF-associated cognitive impairment is generally regarded as a consequence of advanced cerebral structure changes such as white matter lesions [6] , brain atrophy [7, 8] and cerebral hypoperfusion [9] . Many patients with VRFs, however, have already suffered from cognitive impairment for a long time before the signs of cerebrovascular disease appeared. Thus, we speculate that there may be some more sensitive biomarkers like neuronal metabolites at the early stage of VRF-associated cognitive impairment.
A low-invasive measurement of metabolite concentrations using proton magnetic resonance spectroscopy ( 1 H MRS) has been applied in numerous clinical (including neurological) studies. Several metabolites are mainly used in brain MRS study. For instance, N-acetylaspartate (NAA) is used as a marker of neuronal density and plasticity [10] . Glutamate is the major excitatory neurotransmitter and is involved in almost all central neural system (CNS) functions, particularly in those of cortical and hippocampal regions. Excessive Glx neurotransmission is implicated in excitotoxic neuronal damage [11] , so, total glutamate+glutamine concentration (Glx) measured by MRS is used in brain studies [12] . Levels of two metabolites such as choline (Cho), reflecting cellular membrane integrity and Inositol (Ins), which may act as an osmoregulator, intracellular messenger and detoxication agent, can be also regarded as indicative parameters in brain studies [13] . Creatine (Cr), an indicator of cellular energy metabolism, is often used as a putative internal standard because Cr levels tend to remain relatively unchanged [13] . Some changes in brain metabolism are observed even at very early stage of dementia [14] or in cognitively intact elderly subjects [15] , hence, alterations in concentrations of brain metabolites may be served as early biomarkers of VRF-associated cognitive impairment.
Previous studies have demonstrated that VRFs such as hypertension and diabetes can disturb brain metabolism [15, 16] . These studies, mainly explored the effect of single VRF on the brain metabolism, however the presence of multiple risk factors might have synergistic effect [17, 18, 19] . Therefore, a combined assessment of various VRFs will be more accurate when evaluating the pathophysiological basis of VRF-associated cognitive impairment. Framingham stroke risk profile (FSRP) [20] is a useful tool to assess combination of VRF burden and can help to determine quantitatively whether various levels of stroke risk correlate with various levels of brain metabolism alteration.
This study examines the hypothesis that increased FSRP score relates to abnormal brain metabolism in left hippocampus and in left prefrontal cortex independently on concomitant visible cerebral damage. Furthermore, the study analyses whether the association between FSRP score and cognitive impairment is mediated by the changes in levels of brain metabolites.
Methods Subjects
Totally, 54 patients (29 male and 25 female; mean age, 65.6 ± 8.8 years) with various VRFs were recruited for this study. All subjects underwent 1 H MRS, a series of cognitive tests (described below) and a complete risk factor assessment according to the FSRP. Subjects with contraindications to MR scan, a history of stroke or other CNS disease, such as tumour, intracranial infection, demyelinating diseases, were excluded from this study. The study was approved by the medical ethics committee of Zhongnan Hospital, Wuhan University. Written informed consent was obtained from all participants (Clinical research registration number: chiCTR-RNC-12002205).
Vascular risk factors
Risk factors were determined based on medical history and clinical examination. Systolic blood pressure was recorded as the average of three nurse-recorded measurements taken on the right arm with the informant in a seated position after 5 min rest. Diabetes was defined as a previous diagnosis of diabetes or use of hypoglycaemic agents or insulin. Participants were categorised as current cigarette smokers or non-current cigarette smokers. Previous diagnoses of cardiovascular disease (defined as coronary artery disease), atrial fibrillation and left ventricular hypertrophy (V 1 S + V 5 R > 4.0 mV for men or >3.5 mV for women according to the ECG) were evaluated.
Framingham stroke risk profile FSRP score was widely used to predict the probability of 10-year stroke incidence in stroke-free individuals and was calculated as described [20] . Briefly, the risk factors included in the FSRP are age, systolic blood pressure, use of antihypertensive medication, diabetes, smoking status, cardiovascular disease, atrial fibrillation and left ventricular hypertrophy. The score ranges from 1 to 40 points for men and 1 to 44 points for women. The sex-specific score is then transformed to 10-year probability of stroke ranging from 3 to 88% for men and 1 to 84% for women. In order to explore the dose-response relationship, all subjects were divided into three groups according to their 10-year probability of stroke, <10% (low-risk group), 10-20% (medium-risk group), >20% (high-risk group).
Neuropsychological assessment
Cognitive status of all subjects was assessed by trained technicians. Six cognitive scales designed to assess a full range of cognitive functions including global cognitive function, memory, executive function and psychomotor speed. Details of cognitive scales can be found in Supplementary data available in Age and Ageing online, Appendix S1.
MR scan and post-processing
Conventional magnetic resonance imaging (MRI) scan can be found in Supplementary data available in Age and Ageing online, Appendix S1. After standard MRI, single voxel 1 H MRS was conducted according to the following protocol. Point resolved spectroscopy sequence, echo time 135 ms, repetition time 1,600 ms, field of view 240 × 240 mm, matrix 18 × 18, voxel size 10 × 10 × 10 mm 3 , the number of excitations was 128. We choose the left hippocampus and left prefrontal cortex as the volume of interests (VOIs). The concentrations of metabolite were determined by the area of peaks. Spectrum data were analysed using LC-Model (version 6.0; LC-Model Inc., Oakville, ON, Canada). Resonance peaks were assigned as follows: NAA, 2.0 ppm; Glx, 2.1-2.5 ppm; Cr, 3.02 ppm; Cho, 3.2 ppm; Ins, 3.56 ppm. Metabolite concentrations (mmol/L brain tissue) were calculated using tissue water signal as an internal reference. For signal correction of metabolites, longitudinal T1 and transverse T2 values were referred to the values of the gray matter reported by Kreis [21] and to those of the hippocampus reported by Choi [22] . Total glutamate plus glutamine concentration were determined and given as Glx. NAA/Cr, Cho/Cr and Glx/Cr ratios were calculated.
Statistical analysis
SPSS 17 (SPSS Science Inc., Chicago, IL, USA) and Prism 5 (GraphPad Software, La Jolla, CA, USA) were used for data analysis. Normality was checked using the Shapiro-Wilk test. Group comparisons of clinical and demographic data were conducted using analyses of variance for continuous variables and χ 2 -tests for categorical variables. Between-group differences in cognitive performance or 1 H MRS across three FRSP groups were assessed with an overall analysis of covariance model. Bayes discriminant analysis was used to identify the combined effect of each VRF important for discrimination the risk of cognitive impairment. Subsequently, Pearson analysis and partial correlation analysis were used to correlate the FSRP scores with cognitive performance and 1 H MRS data from various brain areas. The analyses were adjusted for white matter hyperintensities (WMHs) volume and presence of lacunes. For each correlation analysis, the partial correlation coefficient and the P-value were determined, when P-value was <0.05 in two-sided test, correlation was considered as statistically significant. Table 1 presents the demographic characteristics and conventional MR findings for all subjects (n = 54). We observed an age imbalance across the three groups, with a predominance of elderly in the high-risk group. Regarding to individual stroke risk factors, systolic blood pressure, left ventricular hypertrophy and antihypertensive therapy was significantly different among the three groups. The high-and mediumrisk group had larger WMHs volume than low-risk group. Bayes discriminant analysis showed that systolic pressure, presence of diabetes, age and current smoking were the major factors leading to cognitive impairment. The overall prediction accuracy was 85.2%. Further details of this analysis can be found in Supplementary data available in Age and Ageing online, Appendix S2. Table 2 shows the within-group differences for cognitive tests and brain metabolites. Compared with low-risk group, the executive function (assessed by digit symbol test) and delayed recall (assessed by RAVLT) were significantly impaired in both the medium-and high-risk group. The scores in global cognitive tests, the trail making tests B and the digit span backward tests were also significantly lower in high-risk group, but not in the medium-risk group. The results of 1 H MRS are shown in Table 2 . In summary (i) compared with low-risk group, NAA/Cr ratios were significantly lower in the regions of hippocampus and prefrontal cortex in both the medium-and high-risk group. (ii) Glx/Cr ratios were significantly reduced in the regions of hippocampus and prefrontal cortex in both the medium-and high-risk group. (iii) The reductions of NAA/Cr and Glx/Cr ratios in hippocampus and of Glx/Cr ratios in prefrontal cortex were more prominent in the high-risk group than in the mediumrisk group. (iv) There were no significant differences in Cho/ Cr and Ins/Cr ratios across the three groups.
Results
As presented in Table 3 , across all subjects, there was a significant negative correlation between FSRP score and cognitive performance, including global cognitive test, executive function, working memory and delayed memory. Higher FSRP score was significantly associated with lower Glx/Cr ratio in hippocampus and with lower NAA/Cr ratio in prefrontal cortex. All associations were adjusted for WMHs volume and presence of lacunes. Pearson correlation analysis showed that lower prefrontal cortex NAA/Cr ratios were associated with lower performance in executive function assessed by digit symbol test. Similarly, lower hippocampus Glx/Cr ratios were associated with lower performance in delayed recall. No significant associations were found between Cho/Cr and Ins/Cr ratios and cognitive performance.
Discussion
The main finding of this cross-sectional study suggests that higher scores in stroke risk factors are associated with the decreased NAA/Cr and Glx/Cr ratios in both left prefrontal cortex and left hippocampus. Furthermore, these brain metabolic changes are associated with lower performance in cognitive function.
Although cognitive impairment has been widely reported in stroke-free adults with various VRFs [4, 5], particularly those with high FSRP scores [3, 23, 24] , the consensus has not yet been reached concerning which cognitive domains are more vulnerable to VRFs. Our results suggest that delayed memory and executive function probably constitute two major cognitive domains involved in VRF-associated cognitive impairment, that is, consistent with some previous studies [23, 25] . In addition, we find that the combination of systolic pressure, presence of diabetes, age and current smoking was the best combined model to predict cognitive impairment. Hippocampus is essential for the episodic memory system. After preprocessing in the entorhinal cortex and dentate gyrus, hippocampus allows the memory to be stored and recalled [26] . VRFs were demonstrated to cause hippocampal hypoperfusion [9] , impair cerebral vasoreactivity [27] and promote Aβ deposition [28] , which can partially account for the delayed memory impairment in VRFassociated cognitive impairment. Executive functions, as assessed by digit symbol tests and trail making tests B in the present study, were also remarkably impaired in the high-risk group. It has been well known that FSRP score was related to WMHs volume [29] and that patients with large WMHs volume performed significantly worse in the cognitive domains generally associated with frontal lobe systems [30] . However, the white matter lesions of subjects inspected in our study were not serious, and the relationship between executive dysfunction and FSRP score remained unchanged after adjustment for WMHs volume and presence of lacunes, which indicated that there may be other mechanisms in addition to ischaemic lesions. It has been widely accepted that the cognitive impairment associated with FSRP score has been largely attributed to cerebral atherosclerosis and subsequent cerebral circulation impairment. Our study has added a new viewpoint that combined VRFs affect cognitive function at the level of neurotransmission as well, represented as a negative relationship between FSRP score and both Glx/Cr ratios in hippocampe and NAA/Cr ratios in prefrontal cortex.
Glutamate, the most abundant neurotransmitter in cerebral cortex and hippocampus, is essential to memory formation through long-term potentiation, and, on the other hand, it is damaging agent involved in many neurologic diseases [11] . The extracellular concentration of glutamate is much lower than in neurones; hence, most Glx signals detected by MRS can be attributed to the intracellular compartment. The decreased Glx signals reflect the glutamate-glutamine cycle dysfunction as well as leakage from neurones and excessive accumulation of glutamate in synaptic cleft. Previous MRS studies indicated that low level of hippocampal glutamate was associated with impaired memory function in AD [31] and other cognitive disorders [32] . In the present study, hippocampal Glx/Cr ratio was significantly decreased in the high-risk group, and was associated with impaired delayed memory. On these grounds, we could speculate that decreased hippocampal Glx/Cr, independent of detectable cerebral lesions, may mediate the association between combined VRFs and cognitive impairment.
Alternative explanations might account for the effects of combined VRFs on hippocampal Glx metabolism. First, lower levels of Glx may result from reduced glutamate synthesis via the tricarboxylic acid, due to inhibition of the mitochondrial function as a result of impaired cerebral blood flow (CBF) and oxidative stress. Hypertension and diabetes mellitus can significantly impair the regional CBF and lead to oxidative injury [9, 33, 34] . Second, it has been well known that VRFs are amyloidogenic [28] , and increased Aβimpaired the glutamate-glutamine cycle [35] .
Similar to previous studies [16, 36] , we also found that high FSRP score was associated with both reduced prefrontal NAA/Cr ratio and executive dysfunction. NAA is an important predictor of neuronal dysfunction and abnormalities of neuronal structures. These findings indicate that the neuronal loss/dysfunction of prefrontal cortex may mediate the association between combined VRFs and executive dysfunction.
Conclusion
This cross-sectional analysis shows that combined VRFs mainly affect the executive function and delayed memory. The glutamatergic system dysfunction, independent of white matter lesions, appears to play an important role in the pathophysiology of VRF-associated cognitive impairment. Brain metabolites and neurotransmitters detected by 1 H MRS may serve as important markers for monitoring VRF burden and possibly treatment effects. Future studies are recommended to evaluate the effectiveness of therapeutic options acting on glutamatergic neurotransmission in the treatment or prevention cognitive impairment associated with VRFs.
Key points
• Delayed memory and executive function were more strongly impaired in stroke-free patients with higher FSRP score.
• FSRP score was associated with abnormal brain metabolites and neurotransmitters detected by 1 H MRS.
• Decreased glutamatergic neurotransmitters may mediate the cognitive impairment in stroke-free patients with VRFs.
